Hester Biosciences Ltd
NSE:HESTERBIO

Watchlist Manager
Hester Biosciences Ltd Logo
Hester Biosciences Ltd
NSE:HESTERBIO
Watchlist
Price: 2 403.9 INR 0.92% Market Closed
Market Cap: 20.4B INR
Have any thoughts about
Hester Biosciences Ltd?
Write Note

Gross Margin
Hester Biosciences Ltd

71.1%
Current
69%
Average
63.9%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
71.1%
=
Gross Profit
2.2B
/
Revenue
3.1B

Gross Margin Across Competitors

Country IN
Market Cap 20.4B INR
Gross Margin
71%
Country FR
Market Cap 6T USD
Gross Margin
0%
Country US
Market Cap 316.5B USD
Gross Margin
67%
Country US
Market Cap 141.2B USD
Gross Margin
60%
Country US
Market Cap 117.1B USD
Gross Margin
78%
Country US
Market Cap 105.3B USD
Gross Margin
86%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 135.7B AUD
Gross Margin
52%
Country US
Market Cap 78.2B USD
Gross Margin
87%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country NL
Market Cap 36B EUR
Gross Margin
89%
No Stocks Found

Hester Biosciences Ltd
Glance View

Market Cap
20.4B INR
Industry
Biotechnology

Hester Biosciences Ltd. is a holding company, which engages in the manufacture and trade of poultry vaccines and animal health products. The company is headquartered in Ahmedabad, Gujarat and currently employs 584 full-time employees. Its segments include Poultry division and Animal division. The company provides over 40 products across poultry vaccines (live and inactivated), animal vaccines (live and inactivated), health products and diagnostics. Its product range includes vaccines, drugs, feed supplements and disinfectants. The company manufactures over two live vaccines for large animals, including Peste des Petits Ruminants (PPR) Live vaccines and Goat Pox Vaccine. Its offerings include Avian, including Live B1, Live LAS, Live R2B, Live M48, Live FP, Gumboro M1, Gumboro I and Gumboro I+; swine fever vaccines, and animal, including PPR Vaccine-Sungri 96 strain and Brucella abortus (S19) calf Vaccine. The company offers services, such as seromonitoring for poultry farms and mastitis prevention programs for cattle farms.

HESTERBIO Intrinsic Value
1 593.33 INR
Overvaluation 34%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
71.1%
=
Gross Profit
2.2B
/
Revenue
3.1B
What is the Gross Margin of Hester Biosciences Ltd?

Based on Hester Biosciences Ltd's most recent financial statements, the company has Gross Margin of 71.1%.